Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.84

+2.8%

Nov 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (11338)	11/17/1997 11:35:00 PM
From: JOEBT1	Read Replies (6) of 32384

Some more output from my discussion with LGND IR. The following are all near term announcements, meaning this year or early next year. Panretin gel and oral for Kaposi Sarcona--PIII Panretin oral for prostate and ovarian cancer--PI/II Targretin for KS,prostate, lung cancers and diabetes--PI/II Leptin pathway deal Psoriasis trial run by AGN for severe psoriasis--PII Mucontaneous (sp?) toxicity trial by AGN Diabetes 1268 IND by LLY LGND selection of LLY drug Talked to AGN also who verified ALRI delays caused by SEC. I can' insure absolute accuracy of above--based on my notes.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next